Income Statement (LEXARIA/BIOSCIENCE)

Technical Analysis Historical Data Financials News & Analysis

LEXARIA/BIOSCIENCE NEWS

Lexaria Bioscience announces last patient, last visit in Phase 1b GLP-1 study By TipRanks - 3 weeks ago

Lexaria Bioscience (LEXX) announced that its Contract Research Organization has completed the important study milestone known as last patent last visit in Lexarias Phase 1b glucagon-like peptide-1 st… [+1128 chars]...

Read more
Top Stock
CurrencyPrice Chg
BA 		229.52 -1.43
-0.62%
CVX 		154.85 0.85
0.55%
CAT 		418.09 -4.69
-1.11%
INTC 		24.44 -0.04
-0.16%
MSFT 		498.41 0.21
0.04%
DIS 		117.37 -1.47
-1.24%
DOW 		24.14 0.16
0.67%
CSCO 		67.34 0.46
0.69%
GS 		763.92 22.07
2.97%